The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II, single-arm study of denosumab in multiple myeloma patients with renal insufficiency.
 
Elizabeth O'Donnell
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; Bristol-Myers Squibb; Celgene; Takeda
Research Funding - Amgen (Inst); Takeda (Inst)
 
Andrew Jenho Yee
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; Bristol-Myers Squibb; Celgene; Dexcel Pharma; Janssen; Karyopharm Therapeutics; Karyopharm Therapeutics; Takeda
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst)
 
Omar Nadeem
No Relationships to Disclose
 
Brea Lipe
Consulting or Advisory Role - Amgen; celgene; GlaxoSmithKline
Research Funding - Amgen (Inst); Celgene (Inst); cellectar (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); Seagen (Inst)
 
Jacob Laubach
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Janssen Research & Development (Inst)
 
Ehsan Malek
No Relationships to Disclose
 
Andrew Branagan
Consulting or Advisory Role - Pharmacyclics/Janssen; Surface Oncology
 
Robb S. Friedman
No Relationships to Disclose
 
Paul G. Richardson
Consulting or Advisory Role - Celgene; Janssen; Jazz Pharmaceuticals; Karyopharm Therapeutics; Oncopeptides; Sanofi; Takeda
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Oncopeptides (Inst); Takeda (Inst)
 
Ajay K. Nooka
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Oncopeptides; Spectrum Pharmaceuticals; Takeda
Research Funding - Amgen (Inst); Janssen Oncology (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Noopur S. Raje
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen Oncology; Merck; Novartis; Takeda
Research Funding - AstraZeneca (Inst)